US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ping An Biomedical Co., Ltd.

0.1349

-0.0011-0.81%

Pre-market: 0.13490.00000.00%04:00 EDT

Volume:30.18K

Turnover:4K

Market Cap:16.86M

PE:-1.38

High:0.1360

Open:0.1327

Low:0.1292

Close:0.1360

52wk High:1.73

52wk Low:0.1100

Shares:125.00M

Float Shares:97.49M

Volume Ratio:0.44

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.0975

EPS(LYR):-0.0975

ROE:-67.43%

ROA:-14.67%

PB:2.51

PE(LYR):-1.38

Loading ...

Overview Company News Filings

Ping An Biomedical Signs Cooperation Deal With Yuan Sheng Mei Yan

MT Newswires Live

Ping an Biomedical and Yuan Sheng MEI Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales over Three Years

THOMSON REUTERS

Ping an Biomedical Unit to Buy Meridian IP Rights for USD 2.5 Million

Ping An Biomedical wins Nasdaq extension to Nov. 23, 2026 to regain $1 bid-price compliance

Ping An Biomedical files Form 3 as CEO-director Liu Pijun reports 12,250,000 shares

Ping An Biomedical files Form 3; CFO Hongli Yang reports no beneficial ownership

Ping An Biomedical Co. Ltd. Held Shareholder Meeting to Approve Share Capital Changes

Ping An Biomedical Director Liu Qingxian Files Initial Beneficial Ownership Statement

Ping An Biomedical Director Gao Jifeng Files Initial Beneficial Ownership Statement

Ping An Biomedical Co. Ltd. Announces Annual General Meeting of Shareholders

Ping an Biomedical Co Ltd - to Resale up to 13.6 Mln Ordinary Shares by Selling Shareholder - SEC Filing

THOMSON REUTERS

Ping An Biomedical Co. files to sell 13.61M ordinary shares for holders

Ping an Biomedical Co Ltd: Entered Into Securities Purchase Agreements, Agreed to Issue & Sell, in Private Placement 100 Mln Ordinary Shares

THOMSON REUTERS

Ping An Biomedical Raises $4 Million in Private Share Placement

Ping An Biomedical FY2025 revenue drops 61% to CNY 34.1 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/PASW/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PASW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PASW\",,,,,undefined,":{"symbol":"PASW","market":"US","secType":"STK","nameCN":"Ping An Biomedical Co., Ltd.","latestPrice":0.1349,"timestamp":1787342400000,"preClose":0.136,"halted":0,"volume":30180,"hourTrading":{"tag":"盘前","latestPrice":0.1349,"preClose":0.1349,"latestTime":"04:00 EDT","volume":9,"amount":1.2141,"timestamp":1787558418167,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.008088235294117776,"floatShares":97488799,"shares":125000000,"eps":-0.097517,"marketStatus":"Pre-Mkt","change":-0.0011,"latestTime":"08-24 07:37:09 EDT","open":0.13265,"high":0.136,"low":0.1292,"amount":3928,"amplitude":0.05,"askPrice":0.1419,"askSize":100,"bidPrice":0.116,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.097517,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"listingDate":1752811200000,"exchange":"NASDAQ","adjPreClose":0.1349,"preHourTrading":{"tag":"盘前","latestPrice":0.1349,"preClose":0.1349,"latestTime":"04:00 EDT","volume":9,"amount":1.2141,"timestamp":1787558418167,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.4410462355173947},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PASW\",,,,,undefined,":{"symbol":"PASW","floatShares":97488799,"roa":"-14.67%","roe":"-67.43%","lyrEps":-0.097517,"volumeRatio":0.4410462355173947,"shares":125000000,"dividePrice":0,"high":0.136,"amplitude":0.05,"preClose":0.136,"low":0.1292,"week52Low":0.11,"pbRate":"2.51","psRate":"3.32","week52High":1.73,"institutionHeld":0,"latestPrice":0.1349,"eps":-0.097517,"divideRate":0,"volume":30180,"delay":0,"ttmEps":-0.097517,"open":0.13265,"prevYearClose":0.5015,"prevWeekClose":0.1349,"prevMonthClose":0.1212,"prevQuarterClose":0.1634,"fiveDayClose":0.1317,"twentyDayClose":0.124,"sixtyDayClose":0.152},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PASW\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PASW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PASW\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/PASW\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"PASW","date":"2026-08-21","current":-1.383349,"percent":0.791855,"low":-27.642982,"twenty":-14.539467,"median":-10.571067,"eighty":-8.801365,"high":-2.158447,"avg":-11.473806,"sd":4.616262,"marketCap":16938800},"quantilePoints":[{"date":"2025-10-03","current":-27.642982,"twenty":-27.100774,"median":-26.287462,"eighty":-25.474149,"marketCap":22345000},{"date":"2025-10-10","current":-25.389744,"twenty":-26.17821,"median":-25.146005,"eighty":-24.967093,"marketCap":20500000},{"date":"2025-10-17","current":-19.290895,"twenty":-25.340996,"median":-24.517706,"eighty":-21.88626,"marketCap":15582050},{"date":"2025-10-24","current":-18.108958,"twenty":-25.138344,"median":-23.076466,"eighty":-19.303276,"marketCap":14632900},{"date":"2025-10-31","current":-19.067929,"twenty":-25.07255,"median":-19.526371,"eighty":-18.995656,"marketCap":15434450},{"date":"2025-11-07","current":-15.165603,"twenty":-24.766247,"median":-19.290895,"eighty":-18.473632,"marketCap":12259000},{"date":"2025-11-14","current":-15.666895,"twenty":-23.967786,"median":-19.046503,"eighty":-16.622066,"marketCap":12707950},{"date":"2025-11-21","current":-14.436215,"twenty":-23.35533,"median":-18.993416,"eighty":-15.508565,"marketCap":11685000},{"date":"2025-11-28","current":-11.52221,"twenty":-23.076466,"median":-18.775446,"eighty":-14.886858,"marketCap":9364400},{"date":"2025-12-05","current":-12.456059,"twenty":-21.588709,"median":-17.944403,"eighty":-13.956973,"marketCap":10137250},{"date":"2025-12-12","current":-14.54413,"twenty":-19.637491,"median":-16.473929,"eighty":-13.460785,"marketCap":11859250},{"date":"2025-12-19","current":-14.520813,"twenty":-19.415251,"median":-15.69775,"eighty":-13.503287,"marketCap":11869500},{"date":"2025-12-26","current":-15.98453,"twenty":-19.365289,"median":-15.856568,"eighty":-13.636869,"marketCap":13120000},{"date":"2026-01-02","current":-12.492509,"twenty":-19.315657,"median":-15.69775,"eighty":-13.438677,"marketCap":10280750},{"date":"2026-01-09","current":-15.381107,"twenty":-19.166951,"median":-15.393631,"eighty":-12.801755,"marketCap":12675150},{"date":"2026-01-16","current":-5.396992,"twenty":-19.074486,"median":-15.205247,"eighty":-12.608022,"marketCap":4458750},{"date":"2026-01-23","current":-4.480642,"twenty":-19.050788,"median":-14.977877,"eighty":-12.470639,"marketCap":3698200},{"date":"2026-01-30","current":-5.887937,"twenty":-19.016893,"median":-14.673796,"eighty":-11.613586,"marketCap":4876950},{"date":"2026-02-06","current":-2.158447,"twenty":-19.000136,"median":-14.532471,"eighty":-6.397256,"marketCap":3991350},{"date":"2026-02-13","current":-2.409485,"twenty":-18.92316,"median":-14.432992,"eighty":-5.492847,"marketCap":4479250},{"date":"2026-02-20","current":-11.744449,"twenty":-18.809311,"median":-14.296755,"eighty":-5.644968,"marketCap":21808705},{"date":"2026-02-27","current":-10.626959,"twenty":-18.699993,"median":-13.586776,"eighty":-5.863159,"marketCap":19928000},{"date":"2026-03-06","current":-9.787757,"twenty":-18.340335,"median":-13.405515,"eighty":-5.902786,"marketCap":18221665},{"date":"2026-03-13","current":-9.389312,"twenty":-18.043136,"median":-12.797747,"eighty":-6.179719,"marketCap":17536640},{"date":"2026-03-20","current":-9.418561,"twenty":-17.6668,"median":-12.699061,"eighty":-7.517754,"marketCap":17511730},{"date":"2026-03-27","current":-9.501225,"twenty":-17.066477,"median":-12.555599,"eighty":-9.221229,"marketCap":17636280},{"date":"2026-04-02","current":-8.954274,"twenty":-16.473929,"median":-12.498214,"eighty":-8.800038,"marketCap":16677245},{"date":"2026-04-10","current":-9.818585,"twenty":-16.460478,"median":-12.191341,"eighty":-8.806672,"marketCap":18433400},{"date":"2026-04-17","current":-10.993883,"twenty":-16.209906,"median":-11.747549,"eighty":-8.905976,"marketCap":20675300},{"date":"2026-04-24","current":-11.315596,"twenty":-15.990686,"median":-11.587381,"eighty":-8.954274,"marketCap":21260685},{"date":"2026-05-01","current":-10.406821,"twenty":-15.98453,"median":-11.495022,"eighty":-9.053114,"marketCap":19554350},{"date":"2026-05-08","current":-9.904525,"twenty":-15.906194,"median":-11.32502,"eighty":-9.221095,"marketCap":18682500},{"date":"2026-05-15","current":-9.801742,"twenty":-15.728606,"median":-11.139456,"eighty":-9.221764,"marketCap":18533040},{"date":"2026-05-22","current":-10.309274,"twenty":-15.666895,"median":-11.006483,"eighty":-9.389312,"marketCap":19442255},{"date":"2026-05-29","current":-10.26723,"twenty":-15.579034,"median":-10.932191,"eighty":-9.412711,"marketCap":19429800},{"date":"2026-06-05","current":-11.698583,"twenty":-15.4866,"median":-10.963037,"eighty":-9.479827,"marketCap":22169900},{"date":"2026-06-12","current":-11.774737,"twenty":-15.408701,"median":-11.006483,"eighty":-9.495834,"marketCap":22294450},{"date":"2026-06-18","current":-11.799952,"twenty":-15.386117,"median":-11.020313,"eighty":-9.499138,"marketCap":22394090},{"date":"2026-06-26","current":-10.398091,"twenty":-15.299377,"median":-11.063092,"eighty":-9.516145,"marketCap":19629080},{"date":"2026-07-02","current":-11.065526,"twenty":-15.213176,"median":-11.013398,"eighty":-9.539548,"marketCap":20899490},{"date":"2026-07-10","current":-10.047966,"twenty":-15.12692,"median":-10.98619,"eighty":-9.566319,"marketCap":18968965},{"date":"2026-07-17","current":-9.667188,"twenty":-14.996081,"median":-10.853847,"eighty":-9.58516,"marketCap":18308850},{"date":"2026-07-24","current":-8.897492,"twenty":-14.862005,"median":-10.839494,"eighty":-9.566319,"marketCap":16851615},{"date":"2026-07-31","current":-7.74745,"twenty":-14.794539,"median":-10.738245,"eighty":-9.497051,"marketCap":14696900},{"date":"2026-08-07","current":-8.586236,"twenty":-14.66427,"median":-10.678091,"eighty":-9.255274,"marketCap":16316050},{"date":"2026-08-14","current":-8.669252,"twenty":-14.609759,"median":-10.626959,"eighty":-8.915636,"marketCap":16490420},{"date":"2026-08-21","current":-8.880546,"twenty":-14.539467,"median":-10.571067,"eighty":-8.801365,"marketCap":16938800}],"updateTime":1787565969767},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PASW\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653766380","title":"Ping An Biomedical Signs Cooperation Deal With Yuan Sheng Mei Yan","url":"https://stock-news.laohu8.com/highlight/detail?id=2653766380","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653766380?lang=en_us&edition=fundamental","pubTime":"2026-07-22 22:23","pubTimestamp":1784730181,"startTime":"0","endTime":"0","summary":"Ping An Biomedical  said Wednesday it partnered with Yuan Sheng Mei Yan Health Services to expand its health and wellness business, targeting 500 million yuan  in cumulative sales within three years.Under the agreement, Yuan Sheng Mei Yan will support channel development and market expansion, while Ping An Biomedical will provide biotechnology products and technical support.The collaboration is expected to accelerate product commercialization and improve market penetration, according to the company.Shares of Ping An Biomedical were down more than 9% in Wednesday trading.Price: 0.13, Change: -0.01, Percent Change: -9.13","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4159","PAImain","PASW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653653867","title":"Ping an Biomedical and Yuan Sheng MEI Yan Sign Strategic Cooperation Agreement, Targeting RMB 500 Million in Sales over Three Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2653653867","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653653867?lang=en_us&edition=fundamental","pubTime":"2026-07-22 21:50","pubTimestamp":1784728222,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nFWN43O0DO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PASW","BK4159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652411216","title":"Ping an Biomedical Unit to Buy Meridian IP Rights for USD 2.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2652411216","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652411216?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:25","pubTimestamp":1784553958,"startTime":"0","endTime":"0","summary":"Ping An Biomedical unit to buy Meridian IP rights for USD 2.5 millionPing An Biomedical agreed to acquire Hong Kong intellectual property from Meridian Industries via its wholly owned unit Multi Ridge","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260720:nNDL9fysYv:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4159","PASW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638763998","title":"Ping An Biomedical wins Nasdaq extension to Nov. 23, 2026 to regain $1 bid-price compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2638763998","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638763998?lang=en_us&edition=fundamental","pubTime":"2026-05-28 05:01","pubTimestamp":1779915660,"startTime":"0","endTime":"0","summary":"Ping An Biomedical received a second 180-day Nasdaq grace period to regain the $1 minimum bid price, extending the deadline to Nov. 23, 2026.Nasdaq will close the matter if the stock trades at or above $1 for at least 10 consecutive business days during the period.A reverse stock split is under consideration as part of the plan to regain compliance.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 27, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nNDL77VgZJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4159","PASW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625945642","title":"Ping An Biomedical files Form 3 as CEO-director Liu Pijun reports 12,250,000 shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2625945642","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625945642?lang=en_us&edition=fundamental","pubTime":"2026-04-08 19:34","pubTimestamp":1775648040,"startTime":"0","endTime":"0","summary":"Ping An Biomedical disclosed CEO Liu Pijun holds 12,250,000 Class A ordinary shares indirectly via INSPIRETECH LTD, per an initial beneficial ownership filing dated Oct. 14, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 08, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260408:nNDL1dx3kS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4159","PASW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624594999","title":"Ping An Biomedical files Form 3; CFO Hongli Yang reports no beneficial ownership","url":"https://stock-news.laohu8.com/highlight/detail?id=2624594999","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624594999?lang=en_us&edition=fundamental","pubTime":"2026-04-01 18:10","pubTimestamp":1775038235,"startTime":"0","endTime":"0","summary":"Ping An Biomedical filed an initial beneficial ownership statement naming Hongli Yang as CFO, dated Oct. 14, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260401:nNDL7s3ck1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW","BK4159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620226756","title":"Ping An Biomedical Co. Ltd. Held Shareholder Meeting to Approve Share Capital Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2620226756","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620226756?lang=en_us&edition=fundamental","pubTime":"2026-03-19 22:00","pubTimestamp":1773928836,"startTime":"0","endTime":"0","summary":"Ping An Bio held its annual general meeting on March 18, 2026.Shareholders approved changes to authorized share capital to USD 312,500 and the creation of Class B shares with 100 votes per share.Adoption of a second amended and restated memorandum and articles of association was approved.A share exchange was approved to repurchase 12.25 million Class A shares from InspireTech and issue 12.25 million Class B shares to InspireTech.A share consolidation was approved, allowing the board to consolidate up to 1,000 Class A shares into 1 and up to 1,000 Class B shares into 1, with fractional entitlements rounded up.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL5JGHKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4159","IE00BKPKM429.USD","SG9999014039.USD","IE00BGHQF748.EUR","LU2210149790.SGD","NDAQ","IE00BN0W2V16.EUR","PASW","LU2210150020.SGD","LU2095319765.USD","BK4585","IE00B3QW5Z07.USD","IE00BN0W2T93.GBP","SG9999014013.SGD","LU0314104364.USD","IE00BN0W2W23.USD","BK4588","IE00B64PRP62.GBP","SG9999014021.USD","BK4112"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620252949","title":"Ping An Biomedical Director Liu Qingxian Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620252949","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620252949?lang=en_us&edition=fundamental","pubTime":"2026-03-18 22:34","pubTimestamp":1773844455,"startTime":"0","endTime":"0","summary":"Ping An Biomedical reported an initial statement of beneficial ownership by director Liu Qingxian. Liu Qingxian beneficially owned 0.6 million Class A ordinary shares indirectly through Sonic Flash Limited. The date of the event requiring the statement was July 29, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL6MR1Kz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4159","PASW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620251145","title":"Ping An Biomedical Director Gao Jifeng Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2620251145","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620251145?lang=en_us&edition=fundamental","pubTime":"2026-03-18 21:45","pubTimestamp":1773841516,"startTime":"0","endTime":"0","summary":"Ping An Biomedical filed an initial statement of beneficial ownership on Form 3 for director Gao Jifeng. The filing reported that Gao Jifeng beneficially owned no securities as of 07/29/2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 18, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260318:nNDL8W2wxK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW","BK4159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618783926","title":"Ping An Biomedical Co. Ltd. Announces Annual General Meeting of Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2618783926","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618783926?lang=en_us&edition=fundamental","pubTime":"2026-03-10 00:02","pubTimestamp":1773072128,"startTime":"0","endTime":"0","summary":"Ping An Biomedical will hold its annual general meeting in Hong Kong on March 18, 2026. Shareholders will vote on a proposal to increase authorized share capital from USD 50,000 to USD 312,500 and reclassify ordinary shares into Class A shares. They will also vote to create 100 million Class B shares carrying 100 votes per share and to adopt a second amended and restated memorandum and articles of association. Another resolution seeks approval for the board to repurchase 12.25 million Class A shares from InspireTech in connection with issuing 12.25 million Class B shares to InspireTech. Shareholders will also vote on a share consolidation of Class A and Class B shares at up to a 1-for-1,000 ratio, and related amendments to the company’s governing documents to reflect the consolidation.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nNDL2ZZ120:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW","BK4159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611956641","title":"Ping an Biomedical Co Ltd - to Resale up to 13.6 Mln Ordinary Shares by Selling Shareholder  - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2611956641","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611956641?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:55","pubTimestamp":1771019722,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nFWN3Z91DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PASW","BK4159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611195948","title":"Ping An Biomedical Co. files to sell 13.61M ordinary shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2611195948","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611195948?lang=en_us&edition=fundamental","pubTime":"2026-02-14 05:55","pubTimestamp":1771019712,"startTime":"0","endTime":"0","summary":"16:53 EST Ping An Biomedical Co. (PASW) files to sell 13.61M ordinary shares for holders Published first on TheFly – the ultimate source for real-t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ping-an-biomedical-co-files-to-sell-13-61m-ordinary-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ping-an-biomedical-co-files-to-sell-13-61m-ordinary-shares-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4159","PAImain","PASW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611903877","title":"Ping an Biomedical Co Ltd: Entered Into Securities Purchase Agreements, Agreed to Issue & Sell, in Private Placement 100 Mln Ordinary Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2611903877","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611903877?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:46","pubTimestamp":1770932791,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nFWN3Z81DB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PASW","BK4159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611908936","title":"Ping An Biomedical Raises $4 Million in Private Share Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2611908936","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611908936?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:32","pubTimestamp":1770931927,"startTime":"0","endTime":"0","summary":"Ping An Biomedical Co. Ltd. has entered into securities purchase agreements with certain accredited investors for a private placement of 100 million ordinary shares at $0.04 per share, raising a total of $4 million. The transaction, exempt from registration under the Securities Act of 1933, is expected to close within three business days, pending the satisfaction or waiver of customary closing conditions. The shares will be subject to transfer restrictions and have not been registered for public sale in the United States.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system opera","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDLbwrPRG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW","BK4159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2607025080","title":"Ping An Biomedical FY2025 revenue drops 61% to CNY 34.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2607025080","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607025080?lang=en_us&edition=fundamental","pubTime":"2026-01-31 03:12","pubTimestamp":1769800367,"startTime":"0","endTime":"0","summary":"Ping An Biomedical Co. Ltd. reported its financial results for the fiscal year ended September 30, 2025. The company posted total revenue of CNY 34.1 million  for the period. Sales of yarns amounted to CNY 32.4 million , while sales of finished garments totaled CNY 1.7 million . The company recorded a revenue decrease of 61.0 percent for the year ended September 30, 2025. Cost of revenue was CNY 33.2 million , with costs of yarns at CNY 31.8 million  and costs of finished garments at CNY 1.4 million .Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ping An Biomedical Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Secur","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nNDL4t3J5B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PASW","BK4159"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":15,"code":"91000000","status":"200"}]}}